Login / Signup

Circulating Calprotectin as a Biomarker of COVID-19 Severity.

Michael MahlerPier-Luigi MeroniMaria InfantinoKatherine A BuhlerMarvin J Fritzler
Published in: Expert review of clinical immunology (2021)
Calprotectin represents a promising serological biomarker for the risk assessment of COVID-19 patients.
Keyphrases
  • sars cov
  • risk assessment
  • coronavirus disease
  • disease activity
  • rheumatoid arthritis